Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial of Elemene Injection/Elemene Oral Emulsion in Combination With Systematic Chemotherapy Including Oxaliplatin in the First -Line Treatment of Advanced Primary Liver Cancer

NCT03166553 is registered in ClinicalTrials.gov with BeiJing Yijiayi Medicine Techonoloy Co., Ltd. as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03166553 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial of Elemene Injection/Elemene Oral Emulsion in Combination With Systematic Chemotherapy Including Oxaliplatin in the First -Line Treatment of Advanced Primary Liver Cancer
Lead sponsor
BeiJing Yijiayi Medicine Techonoloy Co., Ltd.
Phase
Not applicable
Overall status
Unknown status
Start date
November 28, 2016
Completion date
November 27, 2019
Enrollment
150 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

advanced primary liver cancer